Africa News Ledger
SEE OTHER BRANDS

The most trusted news from Africa

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on August 21, 2025

From Google to ChatGPT: Is Your Brand Being Found?

From Google to ChatGPT: Is Your Brand Being Found?

Why AI tools like Gemini and ChatGPT favor optimized press releases WASHINGTON , DC, UNITED STATES, August 21, 2025 /⁨EINPresswire.com⁩/ -- Press releases are no longer just for the media. A new white paper from EIN Presswire shows how press releases …

Trump–Putin Summit Leaves Markets Guessing If A ‘Peace Premium’ Is Within Reach

Trump–Putin Summit Leaves Markets Guessing If A ‘Peace Premium’ Is Within Reach

Despite high-profile talks in Alaska, EBC Financial Group notes little progress, keeping uncertainty elevated across oil, grains, and safe-haven assets. DC, UNITED STATES, August 21, 2025 /⁨EINPresswire.com⁩/ -- The highly anticipated Trump–Putin summit …

Oculis Reports Q2 2025 Financial Results and Provides Company Update

Oculis Reports Q2 2025 Financial Results and Provides Company Update

Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat diabetic …

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025

FOSTER CITY, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Manuscript featured in leading open-access scientific journal Alzheimer’s Research …

VAST Data Introduces SyncEngine to Turn Disconnected Enterprise Data  Into Actionable Intelligence

VAST Data Introduces SyncEngine to Turn Disconnected Enterprise Data Into Actionable Intelligence

Remote-First-Company | NEW YORK CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- VAST Data, the AI Operating System company, today announced VAST SyncEngine, a powerful new capability of the VAST AI OS that acts as a universal data router, unifying a high- …

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

OCALA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. In this latest CEO Corner segment, AIM Chief …

Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech

Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech

DURHAM, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the appointment of Jim Anthony …

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)

Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)

SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel, once-daily oral adrenocorticotropic …

BitMEX Launches ‘Copy Wars’ with 100,000 USDT in Rewards to Celebrate New Copy Trading Feature

BitMEX Launches ‘Copy Wars’ with 100,000 USDT in Rewards to Celebrate New Copy Trading Feature

VICTORIA, Seychelles, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BitMEX, the OG crypto derivatives exchange, today announced the launch of the Copy Wars, a campaign celebrating the launch of its new Copy Trading feature. The campaign, which began on 18 August, is …

BitMEX lanza "Copy Wars" con 100.000 USDT en recompensas para celebrar la nueva función de Copy Trading

BitMEX lanza "Copy Wars" con 100.000 USDT en recompensas para celebrar la nueva función de Copy Trading

VICTORIA, Seychelles, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BitMEX, la bolsa de criptoderivados OG, anunció hoy el lanzamiento de Copy Wars, una campaña que celebra la puesta en marcha de su nueva función de Copy Trading. La campaña, que comenzó el 18 de …

GoldHaven Resources Announces Summer Exploration Plans on Magno & Three Guardsman Projects

GoldHaven Resources Announces Summer Exploration Plans on Magno & Three Guardsman Projects

VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. ("GoldHaven" or the "Company") (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce it has mobilized its geological team and has begun its exploration efforts …

Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome

Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome

ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that its NETHERTON NOW awareness …

Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference

Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference

BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …

Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)

Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)

LONDON and CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the vision of patients with …

UroGen Pharma to Present at Upcoming Investor Conferences

UroGen Pharma to Present at Upcoming Investor Conferences

PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate …

Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases

Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases

SOUTH SAN FRANCISCO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first …

Maxus Mining Announces Appointment of Nathan Bridge as Technical Advisor

Maxus Mining Announces Appointment of Nathan Bridge as Technical Advisor

VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the appointment of Mr. Nathan Bridge as a Technical Advisor to the Company. Mr. Bridge brings over a …

Morocco Strategic Minerals Reports Initial Sampling Results from the Tifernine Property

Morocco Strategic Minerals Reports Initial Sampling Results from the Tifernine Property

MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Morocco Strategic Minerals Corporation (TSXV: MCC) (“Morocco Strategic Minerals” or the “Corporation”) is pleased to announce results from its July 2025 channel and grab sampling program on the Tifernine Property …

Corporation de Minéraux Stratégiques du Maroc publie les premiers résultats d’échantillonnage de la propriété Tifernine

Corporation de Minéraux Stratégiques du Maroc publie les premiers résultats d’échantillonnage de la propriété Tifernine

MONTRÉAL, 21 août 2025 (GLOBE NEWSWIRE) -- Corporation de Minéraux Stratégiques du Maroc (TSXV : MCC) (« Corporation de Minéraux Stratégiques du Maroc » ou la « Société ») a le plaisir d’annoncer les résultats de son programme d’échantillonnage en rainures …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions